Ethoxycarbonyl Group

Ethoxycarbonyl Group

SCHEMBL28038697

CCOC=O.CS(=O)(=O)CCCCn1ccc2cc(Cl)ccc21

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
ACLY P53396 2/20 0.40
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
KRAS P01116 1/20 0.36
RORC P51449 2/20 0.36
PLG P00747 1/20 0.35
PLAU P00749 1/20 0.35
MCL1 Q07820 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
KMO O15229 1/20 0.34
BPTF Q12830 2/20 0.34
HTR2B P41595 1/20 0.34
NPY5R Q15761 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethoxycarbonyl Group SCHEMBL27417453 0.86 HTR2A (0.45) HTR2AHTR2CACLYCDK4CCND1
SCHEMBL29703068 0.85 HTR2A (0.50) HTR2AHTR2CACLYCDK4CCND1
Ethoxycarbonyl Group SCHEMBL27449974 0.84 HTR2A (0.47) HTR2AHTR2CACLYCDK4CCND1
Ethoxycarbonyl Group SCHEMBL27418243 0.81 HTR2A (0.49) HTR2AHTR2CCDK4CCND1KRAS
Ethoxycarbonyl Group SCHEMBL28746661 0.76 HTR2A (0.44) HTR2AHTR2CACLYCDK4CCND1
SCHEMBL27682298 0.76 HTR2A (0.48) HTR2AHTR2CACLYCDK4CCND1
Ethoxycarbonyl Group SCHEMBL27450453 0.74 SLC6A2 (0.44) HTR2AHTR2CKRASPLGPLAU
SCHEMBL18856947 0.74 HTR2A (0.55) HTR2AHTR2CACLYCDK4CCND1
SCHEMBL18856955 0.73 HTR2A (0.56) HTR2AHTR2CACLYCDK4CCND1
Ethoxycarbonyl Group SCHEMBL28823657 0.71 HTR6 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105392787-A Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN LA ROCHE 2016-03-09 CN disclosed